Intrinsic Value of S&P & Nasdaq Contact Us

XORTX Therapeutics Inc. XRTX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • CA • USD

SharesGrow Score
49/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — XRTX

XORTX Therapeutics Inc. (XRTX) has a market capitalization of $601.54K and trades at $2.16. The 52-week range is 0.37-7.05.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.6, Earnings Per Share (EPS) of $-3.90.

The stock has a beta of 0.09, operates in the Healthcare sector.

Trading Data
Current Price$2.16
52-Week Range0.37-7.05
Volume39.89K
Avg Volume (30D)58.97K
Market Cap$601.54K
Beta (1Y)0.09
Company
IPO Date2021-09-23
Employees2
CEOAllen Warren Davidoff
CountryCA
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINCA98420Q3061
CUSIP98420Q207
Income (Latest Year)
Gross Profit$-156.66K
EBITDA$-4.39M
Operating Income$-4.55M
Net Income$-3.71M
EPS$-3.90
EPS Diluted$-3.90
Shares Outstanding$946.93K
Balance Sheet (Latest Year)
Total Assets$3.68M
Current Assets$1.33M
Cash & ST Investments$1.19M
Total Liabilities$821.18K
Total Debt$51.11K
Net Debt$-1.13M
Total Equity$2.86M
Debt / Equity0.02
Valuation Ratios
P/E Ratio-0.6
P/B Ratio0.21
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message